Profile
With over 40 years of experience in clinical oncology and scientific research, Professor Tang has presided over and undertaken 15 oncology research projects, including 1 National Natural Science Foundation General Project and 4 provincial/ministerial-level research projects. He has published 35 academic papers in core journals. He has been awarded one Third Prize for Scientific and Technological Progress of Guangzhou City and three provincial/municipal scientific and technological achievement awards. With more than 20 years of experience as a department director and academic leader, he has trained nearly 30 associate senior-level and below professionals and visiting scholars.
Positions
· Standing Committee Member, Particle Therapy Group, Committee of Cancer Microinvasive Therapy, Chinese Anti-Cancer Association; Standing Committee Member, Particle Therapy Branch; Committee Member, Minimally Invasive Experts Committee for Oncologic Surgery; Deputy Director, Specialty Committee
· Committee Member, Professional Committee on Tumor Radioactive Seed Brachytherapy, Interventional Physician Branch, Chinese Medical Doctor Association
· Deputy Director, Interventional Physician Branch, Guangdong Medical Doctor Association
· Standing Committee Member, Medical Imaging Committee, Chinese Association of Integrative Medicine
Speciality
His primary research focus is minimally invasive interventional therapy for tumors. He possesses extensive clinical experience in comprehensive interventional therapy for advanced cancer patients, interventional therapy for tumor complications, and emergency interventional therapy for oncologic diseases. He specializes in precision treatment for various advanced cancers and holds unique insights into recurrent, metastatic malignancies, and complex cases involving lung cancer, liver cancer, breast cancer, colorectal cancer, gastric cancer, cervical cancer, sarcoma, head and neck cancers, among others.
In Professor Tang Rijie's view, the fight against cancer is a "war." Overcoming it requires not only advanced tools and accurate anticipation but also superior strategy.
In the Third Oncology Department, Professor Tang organizes multidisciplinary team (MDT) consultations daily. The medical team, including surgeons, physicians, interventional radiologists, pathologists, imaging specialists, and nursing staff, gathers in the office for case discussions.
The large TV screen displays various examination reports and images of the patients. Each attending physician presents their patient's specific condition. Professor Tang sometimes takes the mouse, scrolling through the images on the large screen, deliberating and consulting with the team repeatedly before making the final decision on the optimal treatment plan.
"In cancer treatment, it is essential to plan and rationally arrange treatment methods. We hope that from the very first treatment, the cancer can be effectively controlled, aiming to improve the patient's quality of life and prolong survival," says Professor Tang
Professor Tang has adhered to this workflow for over 30 years since beginning his medical practice. He emphasizes that cancer treatment is particularly complex and individualized. "We advocate for personalized management under standardized treatment guidelines. This has two meanings: first standardize, then personalize. Standardization refers to the treatment recommended for a specific disease based on all current research evidence, grounded in evidence-based medicine. On this foundation, personalized management is applied, such as deciding which drugs to use and their dosages."
Over 30 Years Dedicated to Minimally Invasive Interventional Oncology, Exploring Treatments Suitable for Chinese Liver Cancer Patients
Having entered interventional medicine in 1993, Professor Tang has witnessed minimally invasive interventional therapy become one of the most important methods for treating liver cancer, especially advanced stages. Portal vein tumor thrombus is among the most challenging conditions in liver cancer. To tackle it, Professor Tang leverages the advantages of multidisciplinary collaboration, bringing together experts from various fields for discussion and frequently shares advanced experiences and clinical outcomes at renowned domestic and international interventional forums.
Professor Tang Rijie delivering an academic lecture at the 2023 6th Lingnan Summit Forum on Minimally Invasive Interventional Medicine in Guangzhou.
Patients travel from afar—Xinjiang, Liaoning, Guizhou, Hunan, Guangxi, Hainan, and other parts of China—seeking a lifeline and requesting Professor Tang's help.
His approach of heartfelt communication with patients has earned Professor Tang significant trust. He summarizes one key insight: "A patient's trust comes from the doctor's every action—including how the doctor conducts consultations, ward rounds, speaks, and acts. Patients can perceive this."
Utilizing medical skill and compassion to restore hope in cancer patients! On the wards of the Third Oncology Department, Professor Tang and his team face one arduous "battle" after another.
